Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 16.2B | 17.1B | 15.3B | 16.6B |
Cost of revenue | 9.6B | 10.7B | 9.3B | 11.6B |
Gross profit | 6.6B | 6.5B | 6.0B | 4.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | 267.5M |
Other operating expenses | 1.1B | 1.1B | 1.9B | 596.4M |
Operating income | 3.5B | 3.6B | 2.9B | 2.8B |
Non operating interest income | ||||
Income | — | — | — | 59.8M |
Expense | 431.8M | 469.9M | 420.5M | 424.9M |
Other income expense | — | — | — | — |
Pretax income | 3.7B | 3.5B | 2.8B | 2.5B |
Tax provision | 902.9M | 957.5M | 692.2M | 475.7M |
Net income | 2.8B | 2.6B | 2.1B | 2.0B |
Basic EPS | — | 5.7 | 4.6 | 4.4 |
Diluted EPS | — | 5.7 | 4.6 | 4.4 |
Basic average shares | — | 450.9M | 446.8M | 446.8M |
Diluted average shares | — | 450.9M | 446.8M | 446.8M |
EBITDA | 5.9B | 5.5B | 4.1B | 3.7B |
Net income from continuing op. | — | — | 2.8B | 2.5B |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |